AlexandraMcleanStevensMD
Pediatric Hematology & Oncology • Houston, TXAssistant Professor, Pediatrics, Baylor Coll of Med
Dr. Stevens is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6701 Fannin St
Houston, TX 77030Phone+1 832-824-1000Fax+1 832-825-1206
Education & Training
Baylor College of MedicineFellowship, Pediatric Hematology/Oncology, 2010 - 2013
Icahn School of Medicine at Mount Sinai/Kravis Children'sResidency, Pediatrics, 2007 - 2010
Columbia University Vagelos College of Physicians and SurgeonsClass of 2007
Certifications & Licensure
TX State Medical License 2013 - 2025
NY State Medical License 2008 - 2011- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Atovaquone (Mepron®) Combined With Conventional Chemotherapy for de Novo Acute Myeloid Leukemia (AML) Start of enrollment: 2018 Jul 10
Publications & Presentations
PubMed
- 6 citationsLevofloxacin prophylaxis for pediatric leukemia patients: Longitudinal follow-up for impact on health care-associated infections.Andrea Davis, Alexandra M Stevens, Julienne Brackett, Lucila Marquez, Catherine E Foster
Pediatric Blood & Cancer. 2022-07-01 - 18 citationsVenetoclax for Acute Myeloid Leukemia in Pediatric Patients: A Texas Medical Center Experience.Adriana Trabal, Amber Gibson, Jiasen He, David McCall, Michael Roth
Cancers. 2023-03-26 - 54 citationsInterleukin-6 levels predict event-free survival in pediatric AML and suggest a mechanism of chemotherapy resistance.Alexandra M. Stevens, Jennifer Miller, Jaime O. Munoz, Amos Gaikwad, Michele S. Redell
Blood Advances. 2016-12-02
Abstracts/Posters
- Enhancing the Effect of CLL-1 CAR T Cells with Interleukin-15 for Treatment of Acute Myeloid LeukemiaAlexandra McLean Stevens, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Rara Is a Druggable Super-Enhancer Regulated Dependency in Pediatric AMLAlexandra McLean Stevens, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Press Mentions
- Notable Presents Clinical Validation Data from Two Phase 2 Trials in Adult and Pediatric Acute Myelogenous Leukemia at the 63rd American Society of Hematology (ASH) Annual MeetingDecember 16th, 2021
- The Eye of a SurvivorAugust 2nd, 2021
- Honors and GradsJune 29th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
